LABEL Act

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5969 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 5969

   To amend the Federal Food, Drug, and Cosmetic Act to ensure that 
 abortion-inducing drugs bear a label identifying the name and address 
    of the dispenser and the name of the prescriber, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            November 7, 2025

    Mr. Moore of Alabama (for himself, Ms. Hageman, Mrs. Miller of 
 Illinois, Mr. McGuire, Mr. Harris of Maryland, Mr. Palmer, Mr. Clyde, 
 and Mr. Pfluger) introduced the following bill; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
   To amend the Federal Food, Drug, and Cosmetic Act to ensure that 
 abortion-inducing drugs bear a label identifying the name and address 
    of the dispenser and the name of the prescriber, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Linking Abortion-drug Batches for 
Enforcement and Liability Act'' or the ``LABEL Act''.

SEC. 2. LABELING REQUIREMENTS FOR ABORTION-INDUCING DRUGS.

    (a) In General.--Section 503(b) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 353(b)) is amended by adding at the end the 
following:
    ``(6)(A) Notwithstanding any other provision of this Act, in the 
case of an abortion-inducing drug, the drug shall be deemed to be 
misbranded unless the drug bears a label that identifies--
            ``(i) the name and address of the dispenser; and
            ``(ii) the name of the prescriber.
    ``(B) No State or political subdivision of a State may establish, 
continue in effect, or enforce a labeling requirement for an abortion-
inducing drug that is not at least as stringent as the labeling 
requirement in subparagraph (A).
    ``(C) In this paragraph, the term `abortion-inducing drug'--
            ``(i) means a drug that is intended, alone or in 
        combination with 1 or more other drugs, for use or that is in 
        fact used (irrespective of how the drug is labeled) to kill the 
        unborn child of a woman known to be pregnant or to terminate 
        the pregnancy of a woman known to be pregnant; but
            ``(ii) does not include a drug that is intended, alone or 
        in combination with 1 or more other drugs, for use to remove a 
        dead unborn child of a woman known to be pregnant or to treat 
        an ectopic pregnancy.''.
    (b) Severability.--If any provision of this section, the amendment 
made by this section, or the application of such provision or amendment 
to any person or circumstance is held to be unconstitutional, the 
remainder of this section, the amendment made by this section, and the 
application of the provision to such person or circumstance shall not 
be affected thereby.
                                 <all>